ArticleOncology and therapy2022

Measuring the Patient Experience in Rare Disorders: Benefit of Pragmatic Mixed-Methods Research in NUT Carcinoma.

Anna Ciesluk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.